Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Werewolf Therapeutics (HOWL) Return on Assets (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Return on Assets for 5 consecutive years, with 0.85% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets fell 43.0% to 0.85% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.85%, a 43.0% decrease, with the full-year FY2024 number at 0.47%, down 26.0% from a year prior.
  • Return on Assets was 0.85% for Q3 2025 at Werewolf Therapeutics, down from 0.73% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.19% in Q4 2023 to a low of 0.85% in Q3 2025.
  • A 5-year average of 0.39% and a median of 0.33% in 2022 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: rose 15bps in 2023, then plummeted -43bps in 2025.
  • Werewolf Therapeutics' Return on Assets stood at 0.28% in 2021, then dropped by -16bps to 0.33% in 2022, then soared by 40bps to 0.19% in 2023, then plummeted by -176bps to 0.54% in 2024, then crashed by -58bps to 0.85% in 2025.
  • Per Business Quant, the three most recent readings for HOWL's Return on Assets are 0.85% (Q3 2025), 0.73% (Q2 2025), and 0.63% (Q1 2025).